2015 Opportunities in the Papillomavirus Diagnostic Testing Market

April 2015 | 196 pages | ID: 2A86DD71805EN
Venture Planning Group

Abstracts

The report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.

Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

• Hospitals
• Commercial/Private Labs
• Physician Offices
• Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Papillomavirus tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 196 pages and 10 tables

Contents

I. INTRODUCTION

II. HPV/PAPILLOMAVIRUS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests: Pap Smear and HPV
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies

III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solva
Kreatech
Life Technologies
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

List Of Tables

LIST OF TABLES

France: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
France: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment